Literature DB >> 33811117

The Promising Evolution of Targeted Therapeutic Strategies in Cancer.

Solange Peters1, Tony Mok2, Antonio Passaro3, Pasi Antero Jänne4.   

Abstract

The upcoming decade of precision medicine for cancer is moving from the translation of specific genetic findings into clinically relevant improvement to the qualitative analyses of the genomic and immune tumor microenvironment, for an integrated treatment strategy in both metastatic and early disease. ©2021 American Association for Cancer Research.

Entities:  

Mesh：

Year:  2021        PMID： 33811117     DOI： 10.1158/2159-8290.CD-21-0124

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


  2 in total

1.  Targeting S100A9-ALDH1A1-Retinoic Acid Signaling to Suppress Brain Relapse in EGFR-Mutant Lung Cancer.

Authors:  Seoyoung Han; Yifan Tai; Wanchao Ma; Courtney Coker; Anup Kumar Biswas; S Aidan Quinn; Ahmad Rushdi Shakri; Timothy James Zhong; Hanna Scholze; Galina G Lagos; Angeliki Mela; Katia Manova-Todorova; Elisa de Stanchina; Adolfo A Ferrando; Cathy Mendelsohn; Peter Canoll; Helena A Yu; Paul K Paik; Anjali Saqi; Catherine A Shu; Mark G Kris; Joan Massague; Swarnali Acharyya
Journal:  Cancer Discov       Date:  2022-04-01       Impact factor: 38.272

2.  Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations.

Authors:  Antonio Passaro; Ilaria Attili; Alessandra Rappa; Davide Vacirca; Alberto Ranghiero; Caterina Fumagalli; Juliana Guarize; Lorenzo Spaggiari; Filippo de Marinis; Massimo Barberis; Elena Guerini-Rocco
Journal:  Cancers (Basel)       Date:  2021-04-30       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.